All Type of News
Election backlash foreseeable over revision of pharmaceutical affairs law
The Korean Pharmaceutical Association is afraid that the Grand National Party and Chong Wae Dae might crank up efforts to pass a bill from the National Assembly to make cold medicines and fever reducers available at s...
KPMA seeking to suspend temporary production of pharmaceuticals
The Korea Pharmaceutical Manufacturers Association said Wednesday that after heated discussion, it has decided to discontinue the short-term production of drugs as well as other countermeasures as part of efforts to p...
Drug pricing reform should be predictable
The main reason why companies want the pharmaceutical market and the pricing and reimbursement system to be predictable and transparent is that pharmaceutical R&D investment is very long-term and carries a significant...
Policies need to provide better environment for good pharmaceutical firms
The amended law has made doctors and pharmacists as well as pharmaceutical firms subject to punishment if they are found to have been involved in illegal deals. Policymakers hoped this dual punishment clause would red...
Pharmaceutical firms eyes OTC drugs
Domestic drug firms are seeking a breakthrough in their sluggish ethical business by entering more promising over-the-counter (OTC) market as they believe it will create more profits.
Chong Kun Dang Pharmaceutical...
Most firms still sweating over 2012 sales and marketing plans
A majority of sales and marketing executives in domestic pharmaceutical firms are still struggling to finalize their plans for the new year.
The government’s plan to cut drug prices by an average of 17 percent star...
KFDA approves autologous stem cell therapy for patients with Crohn’s disease
Anterogen, a Korean biotechnology venture, announced Tuesday that it will conduct phase I clinical trials in patients with Crohn’s disease with its autologous stem cell therapy from October 25 after obtaining its fina...
KPMA defies government over drug price cut
Vice chairman Kim Yeon-pan of the Korea Pharmaceutical Manufacturers Association declared an all-out struggle against the government’s scheme to squeeze the profits from generics.
The association is collecting sign...
Major firms forecast to suffer profit loss in third quarter
Major Korean pharmaceutical companies are likely to see their third-quarter operating profit worsen, buffeted by tough regulation and their difficulty in reducing promotional expenses, analysts said recently.
Accor...
Lee likely to replace chief aides for social policy
President Lee Myung-bak is expected to appoint new commissioner of Korea Food and Drug Administration in November, according to sources in the ruling bloc.
The current KFDA chief Noh Yun-hong, being considered as t...
